Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 24, 2026
Butterfly Network (BFLY): Assessing the Path to the $11 Analyst Target

Butterfly Network (BFLY): Assessing the Path to the $11 Analyst Target

Key Takeaways

  • The selected price target is $11 per share, the highest current analyst target and a level just above the stock's 52-week high of $10.05.
  • Butterfly Network has delivered record quarterly revenue, raised its full-year guidance, and holds a "Strong Buy" consensus, the strongest bullish factors supporting further upside.
  • The company remains unprofitable with high research and development spending, a key obstacle to sustained appreciation.
  • The $10.05 level represents a critical resistance zone that would need to be cleared before $11 becomes attainable.
  • The key takeaway: reaching $11 is plausible but depends on continued revenue growth and execution rather than on momentum alone.

Why This Price Level Stands Out

Butterfly Network, Inc. (BFLY) develops handheld ultrasound systems built on proprietary ultrasound-on-chip technology. Its point-of-care devices focus on portability and affordability for clinicians. Recent expansions include software and platform offerings such as the Butterfly Embedded program and the Butterfly Garden AI marketplace.

The $11 target matters because it sits just above the 52-week high of $10.05 and aligns with the most bullish analyst forecast. It also represents a roughly 15% gain from recent levels near $9.50, offering a clear benchmark without appearing overly distant.

Current Market Position

The stock has recovered sharply from its 52-week low of $1.34, driven by improved sentiment around the platform transition and better fundamentals. In the second quarter, Butterfly Network posted record revenue of approximately $32.6 million and raised its full-year 2026 outlook to a range of roughly $119 million to $123 million. Analysts project continued double-digit revenue growth into 2027.

Wall Street’s consensus rating stands at “Strong Buy,” with average 12-month price targets ranging from $9.31 to $10.50 depending on the source. Individual targets span from about $5.25 on the low side to $11 on the high end, highlighting differing views on the pace of scaling and profitability.

Potential Drivers for Further Gains

Several developments could support a move toward $11. A co-development and licensing agreement with Midjourney delivered a $15 million upfront fee plus ongoing annual license revenue, adding a software-style income stream. Management has emphasized Butterfly Embedded for integration into third-party devices and the Butterfly Garden ecosystem for partner-developed, FDA-cleared AI applications.

Government opportunities via FedRAMP certification could open doors with agencies such as the Department of Veterans Affairs. The Home & Community Care initiative, aimed at at-home monitoring for conditions like congestive heart failure, offers another long-term avenue. Sustained revenue beats and progress on these newer segments would provide the fundamental backing needed for higher prices. I also checked comparable setups using Tickeron’s AI Screener to see how the stock stacks up against peers.

Obstacles That Could Limit Upside

Profitability remains the primary challenge. Butterfly Network continues to report net losses and negative earnings per share, with elevated research and development costs pressuring results. Because the stock trades mainly on growth expectations, any revenue slowdown, delayed enterprise deals, or guidance miss could weigh on the valuation.

Some independent models suggest the shares trade modestly above estimated fair value, implying that optimistic scenarios may already be priced in. The spread in analyst targets reflects this uncertainty, with several firms maintaining targets of $6 or lower.

Key Technical Levels to Watch

From a technical standpoint, the $10.05 area serves as the main resistance level. A decisive break above it would be necessary for the $11 target to come into realistic reach. On the downside, the $9 psychological level and the broader $8 zone have acted as support where buyers have stepped in previously. Holding above $9 would help maintain the longer-term recovery trend.

Monitoring Momentum with AI Signals

In my analysis of BFLY and similar names, I regularly turn to Tickeron’s AI Daily Buy/Sell Signals to track shifting momentum across thousands of stocks and ETFs. The tool applies artificial intelligence to market conditions and technical behavior, delivering Buy, Sell, or Hold signals that help identify emerging trends without constant manual chart review.

Final Assessment

A move to $11 for Butterfly Network looks ambitious yet attainable given the stock’s position only about 15% below that level, its Strong Buy consensus, record revenue, raised guidance, and expanding platform strategy. These elements provide legitimate support for further appreciation.

That said, the path is not guaranteed. The company is still unprofitable, valuation appears elevated to some models, and the stock must first clear the $10.05 resistance. Investors should track quarterly revenue growth, movement toward profitability, commercialization of the Embedded and Garden platforms, and whether prices hold above key support zones. Reaching $11 will likely hinge on steady execution across these areas.

Using Tickeron for Ongoing Research

Traders looking to follow BFLY alongside other opportunities can explore Tickeron’s AI Daily Buy/Sell Signals for structured, AI-driven insights into momentum and trend shifts. I find it helpful for staying objective when evaluating resistance levels and entry points.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BFLY

BFLY in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 02, 2026

BFLY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 41 cases where BFLY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 65 cases where BFLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

Following a +6.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where BFLY advanced for three days, in 186 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BFLY as a result. In 68 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for BFLY turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 42 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

BFLY moved below its 50-day moving average on September 02, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BFLY crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFLY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for BFLY entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. BFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.965) is normal, around the industry mean (10.728). P/E Ratio (0.000) is within average values for comparable stocks, (68.607). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.677). BFLY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (17.794) is also within normal values, averaging (39.507).

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.56B. The market cap for tickers in the group ranges from 1.86K to 176.55B. ABT holds the highest valuation in this group at 176.55B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -2%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -3%. TNON experienced the highest price growth at 51%, while FEED experienced the biggest fall at -76%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 74
Price Growth Rating: 62
SMR Rating: 89
Profit Risk Rating: 95
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
BFLY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Details
Industry
N/A
Address
1600 District Avenue
Phone
+1 781 557-4800
Employees
220
Web
https://www.butterflynetwork.com
Interact to see
Advertisement
EVCM shares are plunging approximately 23% in premarket trading on March 13, 2026, following the company's Q4 2025 earnings release after the prior session's close. The primary catalyst is a significant EPS miss — EverCommerce reported adjusted EPS of $0.03, badly missing the consensus estimate of $0.05, a 40% negative earnings surprise.
ADBE shares are down approximately 8.67% in premarket trading on March 13, 2026, erasing gains from the prior session. The primary catalyst is the surprise announcement that longtime CEO Shantanu Narayen will step down after 18 years once a successor is named.
ULTA shares are declining sharply in premarket trading on March 13, 2026, extending losses that began after the company's earnings release after the close on March 12 — with the stock down approximately 8.3% in premarket, building on a -4.28% decline during the regular session on March 12. The primary catalyst is fiscal 2026 earnings guidance that fell short of Wall Street expectations, with the company projecting diluted EPS of $28.05–$28.55 against analyst consensus of approximately $28.58.
EONR is trading approximately +10% higher in Friday's premarket session, extending a powerful multi-day rally that has seen the stock surge over 250% year-to-date. The primary catalyst is the company's newly expanded oil hedging program, locking in favorable pricing through 2027 as oil prices spike amid geopolitical tensions in the Middle East.
Shares of El Pollo Loco Holdings (LOCO) surged approximately 15% in early trading on March 13, 2026, following a strong Q4 2025 earnings report released after the close on March 12. The company posted adjusted EPS of $0.25, beating the consensus estimate of $0.21 — a 20.95% earnings surprise — and the highest quarterly beat in recent history.
Shares of Resolute Holdings Management (RHLD) are declining approximately 10% in Friday's session, extending a sharp multi-session downtrend. The primary catalyst is a disappointing full-year and Q4 2025 earnings report released on March 12, 2026, which showed a widening net loss and a Q4 per-share loss of -$0.20 — worse than expectations.
Shares of BW are tumbling approximately 19% in early Friday trading, extending steep losses from the prior session. The primary catalyst is a short-seller report from Wolfpack Research, which publicly disclosed a short position in BW and raised serious questions about the company's flagship $2.4 billion deal.
Trading SOXL (the Direxion Daily Semiconductor Bull 3X ETF), one of the most volatile instruments in U.S. markets, the robot combines 15-minute pattern recognition with Financial Learning Models (FLMs) to extract alpha precisely when human traders are most likely to panic. In today's environment — where war headlines, rate uncertainty, and sector rotation collide — an AI that thrives on volatility isn't a luxury. It's an edge.
In only 6 trading days (March 6–12, 2026), this robot closed 40 trades with a staggering 97.50% win rate, generated $3,429.47 in net profit on $1K-per-trade sizing, and achieved an annualized return of 472.69% with a Profit Factor of 167.59. That is not a typo. While human traders were frozen in fear, this AI was executing with surgical precision — finding breakout entries across four of America's most iconic consumer brands and rotating capital at machine speed.
Gold Fields Ltd (GFI), one of the world’s largest gold producers with mines in Australia, Ghana, South Africa and the Americas, saw its U.S.-listed shares drop more than 10% today. The selloff comes less than a month after the company reported record 2025 profits and unveiled an aggressive capital‑spending and shareholder‑returns plan, and just as the stock trades ex‑dividend. Together, those factors triggered profit‑taking in a name that had rallied strongly into the results and dividend announcement.
ACDC fell over 11% today following the release of Q4 and full‑year 2025 results, reversing part of a roughly 35–40% rally the stock had staged since late 2025.
IPX fell over 14% today, compounding a similar‑sized decline in the previous session; the stock is now down roughly 24% over five days and back into negative territory year‑to‑date. The latest half‑year results showed continued operating losses of around US$34 million, highlighting the capital‑intensive and pre‑profit nature of IperionX’s titanium and critical‑minerals projects.
Shares of NSA stock surged roughly 27% in premarket trading after the company agreed to be acquired by Public Storage in an all-stock transaction valued at about $10.5 billion. The deal values National Storage Affiliates at an implied price of about $41.68 per share, representing a substantial premium to its prior closing price near the low-$30s.
Shares of NBIS jumped roughly 12% in premarket trading after a sharp rally in the prior regular session. The latest leg of the price rally follows news of a multibillion‑dollar, long‑term AI infrastructure agreement with Meta Platforms that expands Nebius’s cloud capacity commitments.
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.